FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology. (Q48393385)

11 February 2018

title

FGF21 and metabolic disease in 2016: A new frontier in FGF21 biology. (English)

1 reference

11 February 2018

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Matthew J Potthoff

series ordinal

1

1 reference

11 February 2018

publication date

16 December 2016

1 reference

11 February 2018

Nature Reviews Endocrinology

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

74-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2016.206

7 June 2020

exact match

0 references

cites work

Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

Novel locus including FGF21 is associated with dietary macronutrient intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

FGF21 Regulates Sweet and Alcohol Preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric Framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

FGF21 is an endocrine signal of protein restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.206

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2016.206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27983736%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference